MARKET

STAA

STAA

Staar Surg
NASDAQ
40.75
+0.64
+1.60%
After Hours: 40.75 0 0.00% 16:16 06/21 EDT
OPEN
40.04
PREV CLOSE
40.11
HIGH
40.94
LOW
39.62
VOLUME
1.17M
TURNOVER
0
52 WEEK HIGH
58.82
52 WEEK LOW
26.66
MARKET CAP
2.00B
P/E (TTM)
131.71
1D
5D
1M
3M
1Y
5Y
Staar Surgical Enhances Governance and Growth Strategy
TipRanks · 8h ago
Weekly Report: what happened at STAA last week (0610-0614)?
Weekly Report · 4d ago
STAAR Surgical: Keeping An Eye On The Shares
Seeking Alpha · 06/13 10:36
Staar Surgical Hosts Investor Presentation Series
TipRanks · 06/12 11:54
STAAR Surgical To Present At Goldman Sachs Global Healthcare Conference; Webcast At 8:00 AM ET
NASDAQ · 06/12 11:01
BTIG Upgrades STAAR Surgical (STAA)
NASDAQ · 06/11 23:59
Analyst Scoreboard: 7 Ratings For Staar Surgical
Staar Surgical (NASDAQ:STAA) is a manufacturer of lenses. The company has an average 12-month price target of $47.57. Staar S surgical has an impressive revenue growth rate of 5.21%. The company makes implantable lenses for the eye and cataracts.
Benzinga · 06/11 19:01
Staar Surgical Price Target Announced at $46.00/Share by BTIG
Dow Jones · 06/11 17:48
More
About STAA
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Webull offers STAAR Surgical Co stock information, including NASDAQ: STAA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STAA stock methods without spending real money on the virtual paper trading platform.